Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GABRIEL L AGUILAR

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1366544371
CMS profile
61682
Location
SAN FRANCISCO, CA

General Payments · PY2018–2024

$1,493.43

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$335.48

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $335.48 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $67.59 3
Oyster Point Pharma, Inc. $66.36 2
ABBVIE INC. $51.80 2
SUN PHARMACEUTICAL INDUSTRIES INC. $44.50 2
RxSight Inc $24.65 1
Bausch & Lomb Americas Inc. $22.45 1
Amgen Inc. $21.49 1
Alcon Laboratories Inc $20.26 1
Dompe US, Inc. $16.38 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $155.67 8
PY2019 $173.19 9
PY2020 $125.71 6
PY2021 $156.60 7
PY2022 $121.60 5
PY2023 $425.18 16
PY2024 $335.48 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $22.53 05/21/2024 Food and Beverage Undisputed 01/23/2026 1125026972 CMS
Abbott Laboratories $22.53 05/21/2024 Food and Beverage Undisputed 01/23/2026 1125026980 CMS
Abbott Laboratories $22.53 05/21/2024 Food and Beverage Undisputed 01/23/2026 1125026986 CMS
ABBVIE INC. $33.53 02/26/2024 Food and Beverage Undisputed 01/23/2026 1103182008 CMS
ABBVIE INC. $18.27 08/06/2024 Food and Beverage Undisputed 01/23/2026 1103182010 CMS
Alcon Vision LLC $20.26 11/13/2024 Food and Beverage Undisputed 01/23/2026 1110597772 CMS
Amgen Inc. $21.49 08/21/2024 Food and Beverage Undisputed 01/23/2026 1111510587 CMS
Bausch & Lomb Americas Inc. $22.45 12/06/2024 Food and Beverage Undisputed 01/23/2026 1140346140 CMS
Dompe US, Inc. $16.38 06/19/2024 Food and Beverage Undisputed 01/23/2026 1151403310 CMS
Oyster Point Pharma, Inc. $32.17 03/28/2024 Food and Beverage Undisputed 01/23/2026 1147426419 CMS
Oyster Point Pharma, Inc. $34.19 10/30/2024 Food and Beverage Undisputed 01/23/2026 1147412162 CMS
RxSight Inc $24.65 01/10/2024 Food and Beverage Undisputed 01/23/2026 1144211986 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $26.19 05/01/2024 Food and Beverage Undisputed 01/23/2026 1152149937 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.31 09/04/2024 Food and Beverage Undisputed 01/23/2026 1152149939 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.